Strategies to apply 3Rs in preclinical testing

Abstract Animal experimentation has been fundamental in biological and biomedical research. To guarantee the maximum quality, efficacy and/or safety of products intended for the use in humans in vivo testing is necessary; however, for over 60 years, alternative methods have been developed in respons...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Susana B. Gorzalczany, Angeles G. Rodriguez Basso
Formato: article
Lenguaje:EN
Publicado: Wiley 2021
Materias:
Acceso en línea:https://doaj.org/article/b7348bda41d3455d9b2921ea78a704b5
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b7348bda41d3455d9b2921ea78a704b5
record_format dspace
spelling oai:doaj.org-article:b7348bda41d3455d9b2921ea78a704b52021-11-16T13:45:54ZStrategies to apply 3Rs in preclinical testing2052-170710.1002/prp2.863https://doaj.org/article/b7348bda41d3455d9b2921ea78a704b52021-10-01T00:00:00Zhttps://doi.org/10.1002/prp2.863https://doaj.org/toc/2052-1707Abstract Animal experimentation has been fundamental in biological and biomedical research. To guarantee the maximum quality, efficacy and/or safety of products intended for the use in humans in vivo testing is necessary; however, for over 60 years, alternative methods have been developed in response to the necessity to reduce the number of animals used in experimentation, to guarantee their welfare; resorting to animal models only when strictly necessary. The three Rs (Replacement, Reduction, and Refinement), seek to ensure the rational and respectful use of laboratory animals and maintain an adequate projection in terms of bioethical considerations. This article describes different approaches to apply 3Rs in preclinical experimentation for either research or regulatory purposes.Susana B. GorzalczanyAngeles G. Rodriguez BassoWileyarticlenon clinicalreductionrefinementreplacementtesting approachesTherapeutics. PharmacologyRM1-950ENPharmacology Research & Perspectives, Vol 9, Iss 5, Pp n/a-n/a (2021)
institution DOAJ
collection DOAJ
language EN
topic non clinical
reduction
refinement
replacement
testing approaches
Therapeutics. Pharmacology
RM1-950
spellingShingle non clinical
reduction
refinement
replacement
testing approaches
Therapeutics. Pharmacology
RM1-950
Susana B. Gorzalczany
Angeles G. Rodriguez Basso
Strategies to apply 3Rs in preclinical testing
description Abstract Animal experimentation has been fundamental in biological and biomedical research. To guarantee the maximum quality, efficacy and/or safety of products intended for the use in humans in vivo testing is necessary; however, for over 60 years, alternative methods have been developed in response to the necessity to reduce the number of animals used in experimentation, to guarantee their welfare; resorting to animal models only when strictly necessary. The three Rs (Replacement, Reduction, and Refinement), seek to ensure the rational and respectful use of laboratory animals and maintain an adequate projection in terms of bioethical considerations. This article describes different approaches to apply 3Rs in preclinical experimentation for either research or regulatory purposes.
format article
author Susana B. Gorzalczany
Angeles G. Rodriguez Basso
author_facet Susana B. Gorzalczany
Angeles G. Rodriguez Basso
author_sort Susana B. Gorzalczany
title Strategies to apply 3Rs in preclinical testing
title_short Strategies to apply 3Rs in preclinical testing
title_full Strategies to apply 3Rs in preclinical testing
title_fullStr Strategies to apply 3Rs in preclinical testing
title_full_unstemmed Strategies to apply 3Rs in preclinical testing
title_sort strategies to apply 3rs in preclinical testing
publisher Wiley
publishDate 2021
url https://doaj.org/article/b7348bda41d3455d9b2921ea78a704b5
work_keys_str_mv AT susanabgorzalczany strategiestoapply3rsinpreclinicaltesting
AT angelesgrodriguezbasso strategiestoapply3rsinpreclinicaltesting
_version_ 1718426500748804096